To inform continued development of the novel immune agent GEN-1, we compared ovarian cancer patients' end points from a neoadjuvant single-arm phase IB study with those of similar historic clinical ...
IMblaze370 evaluated atezolizumab with or without cobimetinib versus regorafenib in patients with mCRC. EC arms were constructed from the Flatiron Health (FH) EHR-derived de-identified database and ...
MONTREAL, QUEBEC, CANADA, May 15, 2025 /EINPresswire.com/ -- Altis Labs, Inc. (“Altis”) will present findings at ISPOR 2025 demonstrating how real-world digital ...
Clinical trials give patients hope — especially when all other available treatments have been exhausted. That hope compels patients to commit a substantial amount of time and effort for the chance to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results